Yew Bio-Pharm Group Inc Stock (OTC: YEWB)

Yew Bio-Pharm Group Inc Stock (OTC:YEWB), Trade Ideas

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ABMD

ACRGF

ADMP

ADMS

ADTN

AERI

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ARDS

ARGGY

ASASF

ASBFY

AUPH

AVCO

AVEW

AXAS

AXDDF

AXGN

AZRX

BCUCY

BEAT

BHKLY

BIEI

BKEAY

BLOZF

BLUU

BTHCF

BYDDY

CARG

CBAY

CDTI

CERS

CHKDP

CHYHY

CLLS

CMPNF

CMVLF

CNPOF

CNSL

CNTMF

CPPMF

CRSXF

CRUUF

CTAIF

CTEQF

CTRA

CTST

CTXR

CXXIF

DERM

DFILF

DMPI

DSFGY

DXBRF

DYMEF

EEGI

EEVVF

ENOB

ESTR

EUUNF

EXXAY

FFXXF

FIXX

FLDM

FLWPF

FRLI

FSSN

FUTL

GEMP

GLMD

GORAF

GYNAF

HABT

HCAT

HEXO

HITIF

HOTH

HSNGY

HTBX

ICPT

IPWR

IRNC

JASN

JCAP

JSHLY

KOPN

KPCPY

KWBT

LBRT

LEMIF

LYFT

MAKSY

Stocks That Hit 52-Week Lows On Thursday

Yew Bio-Pharm Group Inc

Berenberg analyst Peter Richardson initiates coverage on Lloyds Banking Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYG#NYSE">LYG</a>) with a Hold rating and announces Price Target of $2.75.

Price Target

Initiation

Analyst Ratings

Berenberg Initiates Coverage On Lloyds Banking Group with Hold Rating, Announces Price Target of $2.75

The lead marketer for&nbsp;Apple Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) Vision Pro headset,&nbsp;Frank Casanova, has retired, just months <a href="https://www.benzinga.com/news/24/04/38136012/apple-vision-pros-immersive-content-library-to-expand-with-a-dinosaur-film-iphone-16-to-further-boos">after the headset&#8217;s launch</a> and amid a significant drop in demand.
What Happened: Casanova who departed from the tech giant last week had been with Apple for 36 years. He has played a pivotal role in the marketing of the Vision Pro headset along with helping to lead the expansion of the iPhone to new carriers, <a href="https://www.bloomberg.com/news/articles/2024-04-24/apple-s-lead-marketer-for-new-vision-pro-headset-retires?srnd=technology-vp">reported</a>&nbsp;Bloomberg, citing his LinkedIn page. 
The Vision Pro was made available for purchase in early February with a base price of $3,499. Casanova participated in its launch at Apple&#8217;s flagship retail store in the Grove shopping mall in Los Angeles, accompanied by services chief Eddy Cue. 
Dan Riccio, the executive responsible for the development of the device, is approaching retirement.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The retirement of key personnel comes at a critical time for Apple&#8217;s headset business. The Cupertino, California-based tech giant has plans to <a href="https://www.benzinga.com/news/24/03/37910624/apple-sets-sight-on-china-vision-pro-headset-launching-this-year">expand its market to China</a>, a move confirmed by CEO&nbsp;Tim Cook&nbsp;last month, in a video shared on a CCTV account on Weibo.
However, the demand for the Vision Pro has reportedly&nbsp;<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38397921/apple-in-trouble-tim-cook-reportedly-cuts-vision-pro-shipment-forecasts-by-up-to-50">fallen sharply</a>, leading to a significant drop in shipment forecasts. This has forced Apple to re-evaluate its headset business strategy, as noted by analyst&nbsp;Ming-Chi Kuo. The company has reportedly revised its Vision Pro shipment estimates to 400,000-450,000 units for this year, down from the initial 700,000-800,000 units.&nbsp;
Apple&#8217;s struggles in China are not limited to the headset market. The company also faced a <a href="https://www.benzinga.com/government/24/03/37941515/apples-iphone-sales-faces-sharp-decline-in-china-amid-rising-competition">sharp decline in iPhone sales</a> in the country, with a 33% drop in February compared to the last year. 
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:&nbsp;<a href="https://www.benzinga.com/government/24/04/38350596/former-gop-hopeful-nikki-haley-joins-calls-for-tiktok-ban-to-stop-infiltration-of-chinese-communist?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Vision Pro: Why Some Users Have Decided To Return The Headset While Others Can&#8217;t Imagine Going Back Living The Same Way</a>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image courtesy &#8211; Apple

Tech

Media

AAPL

Apple's Top Marketer For Vision Pro Bids Farewell After 36 Years At Cupertino Amid Demand Slump

-Reuters Citing Russian News Agencies Tass, RIA

Belarusian President Lukashenko: Several Dozens Of Russian Nuclear Weapons Deployed In Belarus;  In Case Of Attack On Belarus, Minsk And Moscow Will Instantly Respond With All Kinds Of Weapon

Needham analyst Mike Matson maintains Conmed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNMD#NYSE">CNMD</a>) with a Buy and lowers the price target from $129 to $107.

CNMD

Needham Maintains Buy on Conmed, Lowers Price Target to $107

TD Cowen analyst Andrew Charles maintains Chipotle Mexican Grill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>) with a Buy and raises the price target from $3400 to $3500.

TD Cowen Maintains Buy on Chipotle Mexican Grill, Raises Price Target to $3500

Chinese smartphone maker&nbsp;Xiaomi&nbsp;Corporation&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/XIACY#OTC">XIACY</a>) has reportedly secured 75,723 orders for its SU7 electric sedan as of April 24, aiming to deliver over 10,000 units in June.
The delivery&nbsp;target,&nbsp;revealed during an event at the Beijing auto show, sets a record for an electric vehicle (EV) startup, reported Reuters.
The locked-in orders, representing those with non-refundable deposits, have accumulated within a month of the SU7&#8217;s late March launch, the report added.
Xiaomi eyes over 100,000 SU7 deliveries in 2024, with a commitment to keep its automotive business exclusively focused on the Chinese market for the next three years.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/24/04/38049010/xiaomis-entry-to-an-already-crowded-ev-market-could-make-things-even-worse-for-tesla" rel="noreferrer noopener">Xiaomi&#8217;s Entry To An Already Crowded EV Market Could Make Things Even Worse For Tesla</a>
The report further noted the company expedited deliveries of the standard and Max versions of the SU7 to April 18, 12 days ahead of schedule. Plans for Pro model deliveries&nbsp;are set&nbsp;for late May.
The SU7&#8217;s debut, borrowing design elements from Porsche, ignites a price competition in China&#8217;s EV market, undercutting&nbsp;Tesla Inc&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Model 3 pricing.
Why It Matters: Xiaomi, established in 2010, has built a reputation for high-quality, reasonably priced smartphones. With the SU7, the company aims to replicate this success in the EV industry.
The entire&nbsp;range of&nbsp;the&nbsp;vehicle&nbsp;is expected&nbsp;to&nbsp;be priced&nbsp;between&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/asia/24/01/36838267/latest-tesla-china-rival-xiaomis-first-ev-may-not-be-so-cheap-as-expected" rel="noreferrer noopener">RMB 250,000 ($35,230) and RMB 370,000</a>.
Price Action: XIACY shares closed higher by 2.02% at $10.60&nbsp;on Wednesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Shutterstock

Equities

TSLA

XIACY

Tesla's Latest China Rival Xiaomi Registers Record Bookings For Its EV: Report

Xpeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) Vice Chairman and Co-President Brian Gu expressed his skepticism about the immediate future of <a href="https://www.benzinga.com/news/24/04/38376273/maybe-elon-musk-hints-driverless-teslas-may-debut-in-this-us-state-but-bugs-will-take-few-months-to">self-driving taxis</a> as a lucrative business.
What Happened: Gu, speaking at the Beijing auto show, said that the commercial viability of robotaxis is at least five years away, <a href="https://www.cnbc.com/2024/04/25/xpengs-gu-says-robotaxis-wont-be-a-real-business-for-at-least-five-years.html">reported</a> CNBC on Thursday. This timeline is notably longer than what Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk has suggested. Tesla is actively developing AI software for a robotaxi network.
&#8220;Right now it&#8217;s not something that we are considering when we are launching and planning the sales,&#8221; said Gu. Xpeng, a China-based electric car startup, has made driver-assist software a key selling point.
&#8220;To have a real, full-fledged commercial operation. I think it's more than 5 years away.&#8221;
Despite this, Gu acknowledged the interest in showcasing technology and achieving milestones in China, where companies like Baidu Inc. and Pony.ai have been authorized to charge for fully driverless taxis in certain areas.
See Also: <a href="https://www.benzinga.com/markets/equities/24/04/38395098/tesla-unveils-timeline-for-electric-semi-truck-production-first-units-to-external-customers-by-2?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla Unveils Timeline For Scaling Up Electric Semi-Truck Production, First Units From New Factory To &#8216;Ex</a>
Why It Matters: Musk has been a vocal advocate for the potential of robotaxis, despite challenges such as recent <a href="https://www.benzinga.com/news/24/04/38373389/tesla-ceo-elon-musk-takes-swipe-at-waymo-says-cybertruck-might-be-needed-for-robotaxis-in-san-franci">vandalism incidents</a> and regulatory hurdles. He has even suggested that the <a href="https://www.benzinga.com/news/24/04/38396288/teslas-robotaxi-to-be-called-cybercab-elon-musk-says-self-driving-fleet-will-be-like-combination-of">Tesla Cybertruck</a> might be necessary for robotaxis in San Francisco.
Analysts have also been weighing in on Tesla&#8217;s next-generation vehicle future, with some seeing the company as a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38411281/8-tesla-analysts-size-up-next-gen-vehicles-fsd-ai-and-more-potential-to-be-a-transf">transformational technology company</a> that could deliver outsized returns.
Goldman Sachs analysts have recognized Tesla as a leader in the autonomy and Advanced Driver-Assistance Systems (ADAS) landscape, projecting <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38314733/teslas-autonomous-driving-efforts-win-praise-from-goldman-sachs-wall-street-firm-pr">significant long-term growth</a> from its robotaxi services.
Read Next: <a href="https://www.benzinga.com/news/24/04/38285714/no-more-inventory-discounts-on-tesla-cars-as-ceo-elon-musk-says-sales-system-has-turned-complex-and?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">No More Inventory Discounts On Tesla Cars As CEO Elon Musk Says Sales System Has Turned &#8216;Complex And Inefficient&#8217;</a>
Image Via Shutterstock 
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Kaustubh Bagalkote</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/topic/kaustubh-bagalkote" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

XPEV

Tesla Is betting Big On Robotaxi, But This Rival Thinks Elon Musk's Vision Could Be 'More Than 5 Years Away'

Needham analyst Mike Cikos reiterates MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Buy and maintains $465 price target.

Reiteration

Needham Reiterates Buy on MongoDB, Maintains $465 Price Target

<ul>
<li>Leverage ratio of 4.5%, in line with previous quarter</li>
<li>Provision for credit losses of &euro; 439 million, down 10% from &euro; 488 million in fourth quarter of 2023; full-year guidance reaffirmed at higher end of range of 25-30 basis points of average loans</li>
</ul>

Earnings

Deutsche Bank Reports Q1 Common Equity Tier 1 Capital Ratio Of 13.4% After Deductions For Shareholder Distributions And Business-driven Growth In Risk Weighted Assets

Deutsche Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DB#NYSE">DB</a>) reported quarterly earnings of €0.69 per share which beat the analyst consensus estimate of €0.62 by 11.29 percent. This is a 13.11 percent increase over earnings of €0.61 per share from the same period last year. The company reported quarterly sales of €7.779 billion which beat the analyst consensus estimate of €7.711 billion by 0.89 percent. This is a 1.29 percent increase over sales of €7.680 billion the same period last year.

Earnings Beats

Deutsche Bank Q1 2024 GAAP EPS €0.69 Beats €0.62 Estimate, Sales €7.779B Beat €7.711B Estimate

Bernstein analyst Daniel Roeska initiates coverage on General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) with a Outperform rating and announces Price Target of $55.

Bernstein Initiates Coverage On General Motors with Outperform Rating, Announces Price Target of $55

Wedbush analyst Richard Anderson downgrades First Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FR#NYSE">FR</a>) from Outperform to Neutral and lowers the price target from $59 to $49.

Downgrades

Wedbush Downgrades First Industrial Realty to Neutral, Lowers Price Target to $49

Truist Securities analyst Miller Jump downgrades HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) from Buy to Hold and raises the price target from $27 to $35.

Truist Securities Downgrades HashiCorp to Hold, Raises Price Target to $35

Elon Musk&nbsp;reacted to a user&#8217;s jest about the whereabouts of a former&nbsp;OpenAI chief scientist&nbsp;Ilya Sutskever, after Greg Brockman shared a photo with Sam Altman and&nbsp;Nvidia&nbsp;CEO&nbsp;Jensen Huang. 
What Happened: On Wednesday, Brockman, the president of ChatGPT&#8217;s parent company, took to X, formerly Twitter, and <a href="https://www.benzinga.com/news/24/04/38422652/jensen-huang-hand-delivers-nvidias-first-dgx-h200-gpu-to-openais-sam-altman-to-advance-ai-computing">shared the photo</a> saying, &#8220;First NVIDIA DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &#8216;to advance AI, computing, and humanity.'&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">First <a href="https://twitter.com/nvidia?ref_src=twsrc%5Etfw">@NVIDIA</a> DGX H200 in the world, hand-delivered to OpenAI and dedicated by Jensen &quot;to advance AI, computing, and humanity&quot;: <a href="https://t.co/rEJu7OTNGT">pic.twitter.com/rEJu7OTNGT</a>
&mdash; Greg Brockman (@gdb) <a href="https://twitter.com/gdb/status/1783234941842518414?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Following this, an X user, humorously commented,&nbsp;&#8220;Tell the truth. Is Ilya&nbsp;in the box?,&#8221; to which Tesla and SpaceX CEO&nbsp;Elon Musk responded&nbsp;with a face with tears&nbsp;of joy emoji.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/04/38400945/metas-massive-1b-bet-on-nvidia-h100-gpu-cluster-will-dwarf-every-other-companys-target-but-zuckerber?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Meta&#8217;s Massive $1B Bet On Nvidia H100 GPU Cluster Will Dwarf Every Other Company&#8217;s Target, But Zuckerberg Reveals Original Goal Was This, Not AI</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f602;
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1783262978193948851?ref_src=twsrc%5Etfw">April 24, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The <a href="https://www.benzinga.com/news/24/03/37809836/nvidia-reveals-blackwell-gpu-highlights-partnerships-with-top-companies-at-gtc-the-whole-industry-is">DGX H2000 is being hailed</a> as the most potent GPU globally. The H200 GPU succeeds the highly acclaimed H100 GPU, boasting 1.8 times the memory capacity and 1.4 times the bandwidth of its predecessor.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The mention of&nbsp;Sutskever, OpenAI&#8217;s chief scientist, in the user&#8217;s comment has sparked renewed interest in <a href="https://www.benzinga.com/news/24/03/37814793/sam-altman-laughs-off-speculation-about-openais-ilya-sutskevers-whereabouts-i-really-hope-we-work-to">Sutskever&#8217;s mysterious absence</a>. Sutskever has been missing from the public eye since his <a href="https://www.benzinga.com/23/11/35861681/sam-altman-and-greg-brockman-shocked-and-saddened-after-removal-from-openai-over-google-meet">controversial &#8220;palace coup&#8221; in November</a>. 
His absence has been a subject of speculation, with even Sam Altman, OpenAI&#8217;s CEO, addressing the issue in a podcast. &#8220;I love Ilya. I have tremendous respect for Ilya. I really hope we work together for certainly the rest of my career,&#8221; the OpenAI CEO said in a conversation with Lex Fridman. 
Last year, following OpenAI employees&#8217; <a href="http://benzinga.com/news/23/11/35871393/openais-internal-strife-cto-coo-and-other-employees-unite-in-support-of-sam-altman" target="_blank" rel="noreferrer noopener">open rebellion</a> against the sudden firing of Altman and Brockman, Sutskever said that he would try to reunite the company. &#8220;I deeply regret my participation in the board's actions. I never intended to harm OpenAI,&#8221; he said at the time. 
Helen Toner, another board member who was part of Sutskever&#8217;s bid to remove Altman <a href="https://www.benzinga.com/news/23/11/35912540/sam-altman-tried-to-push-out-another-board-member-before-losing-and-getting-ousted-himself-report">left ChatGPT-parent</a> but Sutskever is still a part of it.
Check out more of Benzinga's Future Of Consumer Tech by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:&nbsp;<a href="https://www.benzinga.com/news/24/04/38357333/elon-musk-reacts-to-tucker-carlson-saying-theres-ton-of-evidence-that-aliens-live-among-us-with-6000?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Tesla CEO Elon Musk Says He Feels &#8216;Like A Wince&#8217; When Saying &#8216;GPU&#8217; As He Boasts Rapid Progress With AI Compute: &#8216;Need A New Word&#8217;</a>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

Elon Musk Laughs As X User Quip On Nvidia CEO Jensen Huang's Picture With Sam Altman And Greg Brockman: 'Is Ilya In The Box?'

Retail pharmacy giant&nbsp;Walgreens Boots Alliance Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) is bolstering its specialty pharmacy services, aiming&nbsp;to enhance patient outcomes and value for stakeholders.
The company unveiled Walgreens Specialty Pharmacy, an encompassing initiative to cater to patients with complex, chronic conditions while fostering profitable partnerships.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/large-cap/24/03/37967312/walgreens-challenges-nearly-1b-arbitration-award-over-alleged-breach-of-covid-19-test-business-con" rel="noreferrer noopener">Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business&nbsp;Contract</a>
Walgreens Specialty Pharmacy introduces a comprehensive suite of services, including gene and cell therapy solutions, marking a significant advancement in the company&#8217;s healthcare offerings.
Anchored by an 18,000-square-foot Innovation Center in Pittsburgh, Pennsylvania, the initiative focuses on managing therapy complexities and ensuring patient success.
Under the expanded business, Walgreens will operate four central specialty pharmacies, each with national accreditations and expertise in dispensing intricate medications.
Additionally, the company&#8217;s expansive network comprises nearly 300 community-based specialty&nbsp;pharmacies,&nbsp;strategically positioned for swift medication access and tailored patient services.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/03/37981845/walgreens-boots-alliance-cuts-higher-end-of-2024-profit-outlook-takes-5-8b-impairment-charge-relate" rel="noreferrer noopener">Walgreens Boots Alliance Cuts Higher End Of 2024 Profit Outlook, Takes $5.8B Impairment Charge Related To VillageMD&nbsp;Business</a>
With over 1,500 specialty-trained pharmacists and 5,000 patient advocacy support members, Walgreens Specialty Pharmacy&nbsp;is primed&nbsp;to address the burgeoning demand for specialized care.
Specialty medications constitute a significant portion of the U.S. prescription drug market, driving the need for tailored solutions.
Walgreens Specialty Pharmacy aims to meet this demand by streamlining care coordination across stakeholders, thereby enhancing patient access and driving cost efficiencies.
Effective August 1, 2024, AllianceRx Walgreens Pharmacy will transition to Walgreens Specialty Pharmacy, offering enhanced resources and clinical support to patients.
Walgreens&nbsp;stock lost over 48% in the last 12 months. Investors can gain exposure to the stock via&nbsp;Invesco High Yield Equity Dividend Achievers ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEY#NASDAQ">PEY</a>) and&nbsp;Invesco Dow Jones Industrial Average Dividend ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DJD#NYSE">DJD</a>).
Price Action: WBA shares are trading higher by 0.79% at $17.94 in premarket at last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Walgreens Expands Specialty Pharmacy Business To Include Gene and Cell Services: Details

HSBC analyst Parash Jain upgrades United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) from Hold to Buy and raises the price target from $150 to $170.

Upgrades

HSBC Upgrades United Parcel Service to Buy, Raises Price Target to $170

Keybanc analyst Kenneth Zener upgrades Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) from Sector Weight to Overweight and announces $400 price target.

Keybanc Upgrades Sherwin-Williams to Overweight, Announces $400 Price Target

PureTech Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTC#NASDAQ">PRTC</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.93) by 74.19 percent. The company reported $3.330 million in sales this quarter. This is a 78.68 percent decrease over sales of $15.618 million the same period last year.

PRTC

PureTech Health FY 2023 GAAP EPS $(0.24) Beats $(0.93) Estimate, Sales $3.330M Down From $15.618M YoY

The CHIPS and Science Act grants of $6.1 billion will support Micron&#39;s plans to invest approximately $50 billion in gross capex for U.S. domestic leading-edge memory manufacturing through 2030. These grants and additional state and local incentives will support the construction of one leading-edge memory manufacturing fab to be co-located with the company&#39;s existing leading-edge R&amp;D facility in Boise, Idaho and the construction of two leading-edge memory fabs in Clay, New York.

Government

Large Cap

Micron Technology And The Biden-Harris Administration Have Signed A Non-binding Preliminary Memorandum Of Terms For $6.1B In Funding Under The CHIPS And Science Act To Support Planned Memory Manufacturing In Idaho And New York

Full-year 2024 revenues are expected to increase&nbsp;1.5%&nbsp;to&nbsp;3.5%&nbsp;on a reported basis and increase&nbsp;1%&nbsp;to&nbsp;3%&nbsp;organically, after excluding the expected impacts of acquisitions, divestitures and foreign currency movements.

Guidance

ALLE

Allegion Reaffirmed FY24 Outlook: Adjusted EPS At $7.00-$7.15 Vs. $7.07 Estimate, Revenue Growth At 1.5%-3.5%